Abstract

Get full access to this article
View all access options for this article.
References
1.World Alzheimer Report 2018 . The state of the art of dementia research: new frontiers . https://www.alz.co.uk/research/WorldAlzheimerReport2018.pdf. Accessed February 17, 2019 .
2.
Ribas
A
Wolchok
JD
. Cancer immunotherapy using checkpoint blockade . Science . 2018 ;359 (6382 ):1350 –1355 .
3.USFDA Novel Drug Approvals and Biological License Application approvals . https://www.fda.gov/Drugs/DevelopmentApprovalProcess/DrugInnovation/ucm592464.htm; https://www.fda.gov/BiologicsBloodVaccines/DevelopmentApprovalProcess/BiologicalApprovalsbyYear/ucm596371.htm. Accessed February 15, 2019 .
4.
Rotte
A
D’Orazi
G
Bhandaru
M
. Nobel committee honors tumor immunologists . J Exp Clin Cancer Res . 2018 ; 37 (1 ):262 .
5.
Oo
C
Sy
KBS
. Fixed-dose combinations: a potential means to boost drug development for selected drugs . Drug Discov Today . 2018 ;23 (3 ):457 –459 .
6.
Hagan
CT
4th
Medik
YB
Wang
AZ
. Nanotechnology approaches to improving cancer immunotherapy . Adv Cancer Res . 2018 ;139 :35 –56 .
7.
Scheiermann
C
Gibbs
J
Ince
L
Loudon
A
. Clocking in to immunity . Nat Rev Immunol . 2018 ;18 (7 ):423 –437 .
